Octreotide acetate
Octreotide acetate was ranked 1089th of 1,796 medicines by items in May 2026, with 260 items, down 13.6% on a year earlier.
Dispensed in May 2026
Rolling 12 months
Net ingredient cost · May 2026
Figure 1. Octreotide acetate: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Use this chart on your site
Free to reuse anywhere, including commercially — on your own site, in a report or in an article. Keep the credit link with it and you are done.
A live chart that updates itself when next month's data lands. The credit line is part of the snippet.
An SVG with the title and credit built in. Vector, so it stays sharp at any size in a slide deck or a print layout, and it opens in Illustrator, Figma, Inkscape or any browser.
Paste this beneath the chart if you are using the image rather than the embed.
Chart licensed under CC BY 4.0 — attribution link to PharmaInsight required. Underlying data © NHSBSA, Open Government Licence v3.0.
At a glance
- Therapeutic class Sex hormones and hormone antagonists in malignant disease
- Presentations 14 shown
- Average cost / item £679.56
- Year on year Down 13.6% on a year earlier
Top presentations, May 2026
The individual products dispensed under Octreotide acetate this month.
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Octreotide acetate is dispensed
The regions and dispensing practices with the highest Octreotide acetate volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Octreotide acetate with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Octreotide acetate is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.